Role of the apical and basolateral domains of the enterocyte in the regulation of cholesterol transport by a high glucose concentration

Biochemistry and Cell Biology

Volumn 91, Issue 6, 2013, Pages 476-486

  Grenier, Emilie ^b   Mailhot, Geneviève ^b   Dion, Danielle ^a   Ravid, Zaava ^a   Spahis, Schohraya ^b   Bendayan, Moise ^a,b   Levy, Emile ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

cholesterol absorption; cholesterol synthesis; cholesterol transporters; glucose; transcription factors

Indexed keywords

ANTICHOLESTEREMIC AGENTS; ANTIGENS, CD36; AZETIDINES; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CARBON RADIOISOTOPES; CELL DIFFERENTIATION; CELL POLARITY; CHOLESTEROL; ENTEROCYTES; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; MEMBRANE PROTEINS; ORPHAN NUCLEAR RECEPTORS; RETINOID X RECEPTOR ALPHA; SCAVENGER RECEPTORS, CLASS B; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

EID: 84894255426     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2013-0053     Document Type: Article

References (83)

1. Affleck J.A. Helliwell P.A. Kellett G.L. 2003. Immunocytochemical detection of GLUT2 at the rat intestinal brush-border membrane. J. Histochem. Cytochem. 51: 1567-1574. 10.1177/002215540305101116. 14566028.
2. Alrefai W.A. Annaba F. Sarwar Z. Dwivedi A. Saksena S. Singla A. Dudeja P.K. Gill R.K. 2007. Modulation of human Niemann-Pick C1-like 1 gene expression by sterol: Role of sterol regulatory element binding protein 2. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G369-G376. 10.1152/ajpgi.00306.2006. 17008555.
3. Altmann S.W. et al 2004. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science, 303: 1201-1204. 10.1126/science. 1093131. 14976318.
4. Alvi F. Idkowiak-Baldys J. Baldys A. Raymond J.R. Hannun Y.A. 2007. Regulation of membrane trafficking and endocytosis by protein kinase C: emerging role of the pericentrion, a novel protein kinase C-dependent subset of recycling endosomes. Cell. Mol. Life Sci. 64: 263-270. 10.1007/s00018-006-6363- 5. 17180302.
5. Brown J.M. Rudel L.L. Yu L. 2007. NPC1L1 (Niemann-Pick C1-like 1) mediates sterol-specific unidirectional transport of non-esterified cholesterol in McArdle-RH7777 hepatoma cells. Biochem. J. 406: 273-283. 10.1042/BJ20070168. 17523925.
6. Cha J.Y. Repa J.J. 2007. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J. Biol. Chem. 282: 743-751. 10.1074/jbc.M605023200. 17107947.
7. Cohen J.C. Pertsemlidis A. Fahmi S. Esmail S. Vega G.L. Grundy S.M. Hobbs H.H. 2006. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc. Natl. Acad. Sci. U.S.A. 103: 1810-1815. 10.1073/pnas.0508483103. 16449388.
8. Courtois F. Suc I. Garofalo C. Ledoux M. Seidman E. Levy E. 2000. Iron-ascorbate alters the efficiency of Caco-2 cells to assemble and secrete lipoproteins. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G12-G19. 10898742.
9. Davies J.P. Levy B. Ioannou Y.A. 2000. Evidence for a Niemann-pick C (NPC) gene family: identification and characterization of NPC1L1. Genomics, 65: 137-145. 10.1006/geno.2000.6151. 10783261.
10. Davis H.R. Jr. Compton D.S. Hoos L. Tetzloff G. 2001. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice. Arterioscler. Thromb. Vasc. Biol. 21: 2032-2038. 10.1161/hq1201.100260. 11742881.
11. Drozdowski L.A. Thomson A.B. 2006. Intestinal sugar transport. World J. Gastroenterol. 12: 1657-1670. 16586532.
12. Duval C. Touche V. Tailleux A. Fruchart J.-C. Fievet C. Clavey V. Staels B. Lestavel S. 2006. Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine. Biochem. Biophys. Res. Commun. 340: 1259-1263. 10.1016/j.bbrc.2005.12.137. 16414355.
13. Feng D. Ohlsson L. Duan R.D. 2010. Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression. Lipids Health Dis. 9: 40. 10.1186/1476-511X-9-40. 20403165.
14. Field F.J. Born E. Chen H. Murthy S. Mathur S.N. 1995. Esterification of plasma membrane cholesterol and triacylglycerol-rich lipoprotein secretion in CaCo-2 cells: possible role of p-glycoprotein. J. Lipid Res. 36: 1533-1543. 7595077.
15. Field F.J. Watt K. Mathur S.N. 2007. Ezetimibe interferes with cholesterol trafficking from the plasma membrane to the endoplasmic reticulum in CaCo-2 cells. J. Lipid Res. 48: 1735-1745. 10.1194/jlr.M700029-JLR200. 17473178.
16. Garcia M.J. McNamara P.M. Gordon T. Kannel W.B. 1974. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes, 23: 105-111. 10.2337/diab.23.2.105. 4359625.
17. Gleeson A. Owens D. Collins P. Johnson A. Tomkin G.H. 2000. The relationship between cholesterol absorption and intestinal cholesterol synthesis in the diabetic rat model. Int. J. Exp. Diabetes Res. 1: 203-210. 10.1155/EDR.2000.203. 11467411.
18. Greenberg M.E. Smith J.D. Sehayek E. 2009. Moderately decreased cholesterol absorption rates are associated with a large atheroprotective effect. Arterioscler. Thromb. Vasc. Biol. 29: 1745-1750. 10.1161/ATVBAHA.109. 194605. 19661480.
19. Grenier E. Schwalm Maupas F. Beaulieu J.-F. Seidman E. Delvin E. Sané A. et al 2007. Effect of retinoic acid on cell proliferation and differentiation as well as on lipid synthesis, lipoprotein secretion, and apolipoprotein biogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G1178-G1189. 10.1152/ajpgi.00295.2007. 17916647.
20. Grenier E. Garofalo C. Delvin E. Levy E. 2012. Modulatory role of PYY in transport and metabolism of cholesterol in intestinal epithelial cells. PLoS. One, 7: e40992. 10.1371/journal.pone.0040992. 22844422.
21. Grigore L. Raselli S. Garlaschelli K. Redaelli L. Norata G.D. Pirillo A. Catapano A.L. 2013. Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia. Eur. J. Clin. Pharmacol. 69 (3): 341-346. 10.1007/s00228-012-1345-z. 22777149.
22. Gu K. Cowie C.C. Harris M.I. 1998. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care, 21: 1138-1145. 10.2337/diacare.21.7.1138. 9653609.
23. Haffner S.M. Foster D.M. Kushwaha R.S. Hazzard W.R. 1984. Retarded chylomicron apolipoprotein-B catabolism in type 2 (non-insulin-dependent) diabetic subjects with lipaemia. Diabetologia, 26: 349-354. 10.1007/BF00266035. 6734981.
24. Haidari M. Leung N. Mahbub F. Uffelman K.D. Kohen-Avramoglu R. Lewis G.F. Adeli K. 2002. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J. Biol. Chem. 277: 31646-31655. 10.1074/jbc.M200544200. 12070142.
25. Harbis A. Defoort C. Narbonne H. Juhel C. Senft M. Latgé C. et al 2001. Acute hyperinsulinism modulates plasma apolipoprotein B-48 triglyceride-rich lipoproteins in healthy subjects during the postprandial period. Diabetes, 50: 462-469. 10.2337/diabetes.50.2.462. 11272161.
26. Hogue J.-C. Lamarche B. Tremblay A.J. Bergeron J. Gagné C. Couture P. 2007. Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. J. Lipid Res. 48: 1336-1342. 10.1194/jlr.M600548-JLR200. 17337758.
27. Kellett G.L. Helliwell P.A. 2000. The diffusive component of intestinal glucose absorption is mediated by the glucose-induced recruitment of GLUT2 to the brush-border membrane. Biochem. J. 350 (1): 155-162. 10.1042/0264-6021: 3500155. 10926839.
28. Kesaniemi Y.A. Miettinen T.A. 1987. Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population. Eur. J. Clin. Invest. 17: 391-395. 10.1111/j.1365-2362.1987.tb01132.x. 3121341.
29. Kramer W. Girbig F. Corsiero D. Pfenninger A. Frick W. Jähne G. et al 2005. Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane. J. Biol. Chem. 280: 1306-1320. 10.1074/jbc.M406309200. 15494415.
30. Lally S. Tan C.Y. Owens D. Tomkin G.H. 2006. Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein. Diabetologia, 49: 1008-1016. 10.1007/s00125-006-0177-8. 16518588.
31. Lally S. Owens D. Tomkin G.H. 2007. Genes that affect cholesterol synthesis, cholesterol absorption, and chylomicron assembly: the relationship between the liver and intestine in control and streptozotosin diabetic rats. Metabolism, 56: 430-438. 10.1016/j.metabol.2006.10.028. 17292734.
32. Levy E. Mehran M. Seidman E. 1995. Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion. FASEB J. 9: 626-635. 7768354.
33. Levy E. Ménard D. Suc I. Delvin E. Marcil V. Brissette L. Thibault L. Bendayan M. 2004. Ontogeny, immunolocalisation, distribution and function of SR-BI in the human intestine. J. Cell Sci. 117: 327-337. 10.1242/jcs.00856. 14676281.
34. Levy E. Spahis S. Sinnett D. Peretti N. Maupas-Schwalm F. Delvin E. Lambert M. Lavoie M.-A. 2007. Intestinal cholesterol transport proteins: an update and beyond. Curr. Opin. Lipidol. 18: 310-318. 10.1097/MOL. 0b013e32813fa2e2. 17495606.
35. Levy E. Lalonde G. Delvin E. Elchebly M. Precourt L.P. Seidah N.G. et al 2010. Intestinal and hepatic cholesterol carriers in diabetic Psammomys obesus. Endocrinology, 151: 958-970. 10.1210/en.2009-0866. 20130116.
36. Levy E. Harmel E. Laville M. Sanchez R. Emonnot L. Sinnett D. et al 2011. Expression of Sar1b enhances chylomicron assembly and key components of the coat protein complex II system driving vesicle budding. Arterioscler. Thromb. Vasc. Biol. 31: 2692-2699. 10.1161/ATVBAHA.111.233908. 21836065.
37. Lewis G.F. Carpentier A. Adeli K. Giacca A. 2002. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23: 201-229. 10.1210/er.23.2.201. 11943743.
38. Mailhot G. Ravid Z. Barchi S. Moreau A. Rabasa-Lhoret R. Levy E. 2009. CFTR knockdown stimulates lipid synthesis and transport in intestinal Caco-2/15 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 297: G1239-G1249. 10.1152/ajpgi.00206.2009. 19808659.
39. Marcil V. Delvin E. Seidman E. Poitras L. Zoltowska M. Garofalo C. Levy E. 2002. Modulation of lipid synthesis, apolipoprotein biogenesis, and lipoprotein assembly by butyrate. Am. J. Physiol. Gastrointest. Liver Physiol, 283: G340-G346. 10.1152/ajpgi.00440.2001. 12121881.
40. Mehran M. Levy E. Bendayan M. Seidman E. 1997. Lipid, apolipoprotein, and lipoprotein synthesis and secretion during cellular differentiation in Caco-2 cells. In Vitro Cell. Dev. Biol. Anim. 33: 118-128. 10.1007/s11626-997-0032-3. 9081219.
41. Miettinen T.A. Gylling H. 2000. Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis, 153: 241-248. 10.1016/S0021-9150(00)00404-4. 11058720.
42. Miettinen T.A. Gylling H. Nissinen M.J. 2011. The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption. Nutr. Metab. Cardiovasc. Dis. 21: 765-769. 10.1016/j.numecd. 2011.05.005. 21899991.
43. Mikhailidis D.P. Sibbring G.C. Ballantyne C.M. Davies G.M. Catapano A.L. 2007. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Curr. Med. Res. Opin. 23: 2009-2026. 10.1185/030079907X210507. 17659159.
44. Murthy S. Born E. Mathur S.N. Field F.J. 2002. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells. J. Lipid Res. 43: 1054-1064. 10.1194/jlr.M100358-JLR200. 12091489.
45. Osswald C. Baumgarten K. Stümpel F. Gorboulev V. Akimjanova M. Knobeloch K.-P. et al 2005. Mice without the regulator gene Rsc1A1 exhibit increased Na+-D-glucose cotransport in small intestine and develop obesity. Mol. Cell. Biol. 25: 78-87. 10.1128/MCB.25.1.78-87.2005. 15601832.
46. Packard C. Olsson A.G. 2002. Management of hypercholesterolaemia in the patient with diabetes. Int. J. Clin. Pract. Suppl. 27-32. 12296606.
47. Papazafiropoulou A. Kardara M. Sotiropoulos A. Bousboulas S. Stamataki P. Pappas S. 2010. Plasma glucose levels and white blood cell count are related with ankle brachial index in type 2 diabetic subjects. Hellenic J. Cardiol. 51: 402-406. 20876052.
48. Peretti N. Delvin E. Sinnett D. Marcil V. Garofalo C. Levy E. 2007. Asymmetrical regulation of scavenger receptor class B type I by apical and basolateral stimuli using Caco-2 cells. J. Cell. Biochem. 100: 421-433. 10.1002/jcb.20882. 16927335.
49. Pihlajamaki J. Gylling H. Miettinen T.A. Laakso M. 2004. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J. Lipid Res. 45: 507-512. 10.1194/jlr.M300368-JLR200. 14657199.
50. Play B. Salvini S. Haikal Z. Charbonnier M. Harbis A. Roussel M. Lairon D. Jourdheuil-Rahmani D. 2003. Glucose and galactose regulate intestinal absorption of cholesterol. Biochem. Biophys. Res. Commun. 310: 446-451. 10.1016/j.bbrc.2003.08.150. 14521930.
51. Praveen E.P. Kulshreshtha B. Lal Khurana M. Prakash Sahoo J. Gupta N. Kumar G. Nand Dwivedi S. Ammini A.C. 2010. Obesity and metabolic abnormalities in offspring of subjects with diabetes mellitus. Diabetes Technol. Ther. 12: 723-730. 10.1089/dia.2009.0163. 20707738.
52. Ravid Z. Bendayan M. Delvin E. Sané A.T. Elchebly M. Lafond J. et al 2008. Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G873-G885. 10.1152/ajpgi.90376.2008. 18772361.
53. Rivellese A.A. De Natale C. Di Marino L. Patti L. Iovine C. Coppola S. et al 2004. Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. J. Clin. Endocrinol. Metab. 89: 2153-2159. 10.1210/jc.2003-031764. 15126535.
54. Roman Y. Alfonso A. Louzao M.C. Vieytes M.R. Botana L.M. 2001. Confocal microscopy study of the different patterns of 2-NBDG uptake in rabbit enterocytes in the apical and basal zone. Pflugers Arch. 443: 234-239. 10.1007/s004240100677. 11713649.
55. Sané A.T. Sinnett D. Delvin E. Bendayan M. Marcil V. Ménard D. Beaulieu J.-F. Levy E. 2006. Localization and role of NPC1L1 in cholesterol absorption in human intestine. J. Lipid Res. 47: 2112-2120. 10.1194/jlr.M600174- JLR200. 16829661.
56. Schaefer E.J. McNamara J.R. Shah P.K. Nakajima K. Cupples L.A. Ordovas J.M. Wilson P.W.F. 2002. Elevated remnant-like particle cholesterol and triglyceride levels in diabetic men and women in the Framingham Offspring Study. Diabetes Care, 25: 989-994. 10.2337/diacare.25.6.989. 12032104.
57. Schöndorf T. Lübben G. Karagiannis E. Erdmann E. Forst T. Pfützner A. 2010. Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists: results from the DIASPORA study. Diab. Vasc. Dis. Res. 7: 145-150. 10.1177/1479164109358241. 20382778.
58. Shirazi-Beechey S.P. 1995. Molecular biology of intestinal glucose transport. Nutr. Res. Rev. 8: 27-41. 10.1079/NRR19950005. 19094278.
59. Simonen P.P. Gylling H.K. Miettinen T.A. 2002. Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care, 25: 1511-1515. 10.2337/diacare.25.9.1511. 12196419.
60. Sonnier D.I. Bailey S.R. Schuster R.M. Lentsch A.B. Pritts T.A. 2010. TNF-alpha induces vectorial secretion of IL-8 in Caco-2 cells. J. Gastrointest. Surg. 14: 1592-1599. 10.1007/s11605-010-1321-9. 20827577.
61. Stamler J. Vaccaro O. Neaton J.D. Wentworth D. 1993. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 16: 434-444. 10.2337/diacare.16. 2.434. 8432214.
62. Sudhop T. Lütjohann D. Kodal A. Igel M. Tribble D.L. Shah S. Perevozskaya I. von Bergmann 2002. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation, 106: 1943-1948. 10.1161/01.CIR.0000034044.95911.DC. 12370217.
63. Syvanne M. Hilden H. Taskinen M.R. 1994. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease. J. Lipid Res. 35: 15-26. 8138716.
64. Teno S. Uto Y. Nagashima H. Endoh Y. Iwamoto Y. Omori Y. Takizawa T. 2000. Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care, 23: 1401-1406. 10.2337/diacare.23.9.1401. 10977041.
65. Tokuno A. Hirano T. Hayashi T. Mori Y. Yamamoto T. Nagashima M. et al 2007. The effects of statin and fibrate on lowering small dense LDL-cholesterol in hyperlipidemic patients with type 2 diabetes. J. Atheroscler. Thromb. 14: 128-132. 10.5551/jat.14.128. 17587764.
66. Tremblay A.J. Lamarche B. Hogue J.C. Couture P. 2009. Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia. J. Lipid Res. 50: 1463-1471. 10.1194/jlr.P800061-JLR200. 19305020.
67. Turley S.D. Dietschy J.M. 2003. Sterol absorption by the small intestine. Curr. Opin. Lipidol. 14: 233-240. 10.1097/00041433-200306000-00002. 12840653.
68. Turley S.D. Daggy B.P. Dietschy J.M. 1994. Psyllium augments the cholesterol-lowering action of cholestyramine in hamsters by enhancing sterol loss from the liver. Gastroenterology, 107: 444-452. 8039621.
69. Valdivielso P. Hidalgo A. Rioja J. Aguilar I. Ariza M.J. González-Alegre T. González-Santos P. 2007. Smoking and postprandial triglycerides are associated with vascular disease in patients with type 2 diabetes. Atherosclerosis, 194: 391-396. 10.1016/j.atherosclerosis.2006. 08.006. 16996523.
70. Veyhl M. Wagner C.A. Gorboulev V. Schmitt B.M. Lang F. Koepsell H. 2003. Downregulation of the Na(+)-D-glucose cotransporter SGLT1 by protein RS1 (RSC1A1) is dependent on dynamin and protein kinase C. J. Membr. Biol. 196: 71-81. 10.1007/s00232-003-0626-y. 14724758.
71. Vidal R. Hernandez-Vallejo S. Pauquai T. Texier O. Rousset M. Chambaz J. Demignot S. Lacorte J.-M. 2005. Apple procyanidins decrease cholesterol esterification and lipoprotein secretion in Caco-2/TC7 enterocytes. J. Lipid Res. 46: 258-268. 10.1194/jlr.M400209-JLR200. 15576849.
72. Vine D.F. Takechi R. Russell J.C. Proctor S.D. 2007. Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome. Atherosclerosis, 190: 282-290. 10.1016/j.atherosclerosis.2006.03.013. 16624317.
73. Vine D.F. Glimm D.R. Proctor S.D. 2008. Intestinal lipid transport and chylomicron production: possible links to exacerbated atherogenesis in a rodent model of the metabolic syndrome. Atheroscler. Suppl. 9: 69-76. 10.1016/j.atherosclerosissup.2008.05.004. 18632312.
74. Weingartner O. Lutjohann D. Bohm M. Laufs U. 2010. Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk. Atherosclerosis, 210: 362-365. 10.1016/j.atherosclerosis. 2010.01.003. 20116793.
75. Wierzbicki A.S. Doherty E. Lumb P.J. Chik G. Crook M.A. 2005. Efficacy of ezetimibe in patients with statin-resistant and statin-intolerant familial hyperlipidaemias. Curr. Med. Res. Opin. 21: 333-338. 10.1185/030079905X28872. 15811200.
76. Wright E.M. Martin M.G. Turk E. 2003. Intestinal absorption in health and disease-sugars. Best Pract. Res. Clin. Gastroenterol. 17: 943-956. 10.1016/S1521-6918(03)00107-0. 14642859.
77. Xiao C. Dash S. Morgantini C. Lewis G.F. 2013. Novel role of enteral monosaccharides in intestinal lipoprotein production in healthy humans. Arterioscler. Thromb. Vasc. Biol. 33: 1056-1062. 10.1161/ATVBAHA.112.300769. 23471231.
78. Yakovich A.J. Huang Q. Du J. Jiang B. Barnard J.A. 2010. Vectorial TGFbeta signaling in polarized intestinal epithelial cells. J. Cell Physiol. 224: 398-404. 10.1002/jcp.22135. 20432436.
79. Yamanashi Y. Takada T. Suzuki H. 2007. Niemann-Pick C1-like 1 overexpression facilitates ezetimibe-sensitive cholesterol and beta-sitosterol uptake in CaCo-2 cells. J. Pharmacol. Exp. Ther. 320: 559-564. 10.1124/jpet.106.114181. 17135346.
80. Young N.L. Lopez D.R. McNamara D.J. 1988. Contributions of absorbed dietary cholesterol and cholesterol synthesized in small intestine to hypercholesterolemia in diabetic rats. Diabetes, 37: 1151-1156. 10.2337/diabetes.37.8.1151. 3391347.
81. Yu L. Bharadwaj S. Brown J.M. Ma Y. Du W. Davis M.A. et al 2006. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J. Biol. Chem. 281: 6616-6624. 10.1074/jbc.M511123200. 16407187.
82. Zhang J.-H. Ge L. Qi W. Zhang L. Miao H.-H. Li B.-L. Yang M. Song B.-L. 2011. The N-terminal domain of NPC1L1 protein binds cholesterol and plays essential roles in cholesterol uptake. J. Biol. Chem. 286: 25088-25097. 10.1074/jbc.M111.244475. 21602275.
83. Zoltowska M. Ziv E. Delvin E. Sinnett D. Kalman R. Garofalo C. Seidman E. Levy E. 2003. Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes. Diabetes, 52: 2539-2545. 10.2337/diabetes.52.10.2539. 14514638.